+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey



The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey



Journal of Pain Research 10: 2525-2538



The prevalence of neuropathic pain (NeP) has been estimated within specific health conditions; however, there are no published data on its broad prevalence in the US. The current exploratory study addresses this gap using the validated PainDetect questionnaire as a screener for probable NeP in a general-population health survey conducted with a multimodal recruitment strategy to maximize demographic representativeness. Adult respondents were recruited from a combination of Internet panels, telephone lists, address lists, mall-based interviews, and store-receipt invitations using a random stratified-sampling framework, with strata defined by age, sex, and race/ethnicity. Older persons and minorities were oversampled to improve prevalence estimates. Results were weighted to match the total adult US population using US Census data. Demographic information was collected, and respondents who experienced physical pain in the past 12 months completed the PainDetect and provided additional pain history. A cutoff score of 19 or greater on the PainDetect was used to define probable NeP. A total of 24,925 respondents (average response rate 2.5%) provided demographic data (52.2% female, mean age 51.5 years); 15,751 respondents reported pain (63.7%), of which 2,548 (15.7%, 95% confidence interval 14.9%-16.5%) had probable NeP based on the PainDetect, which was 10% (95% confidence interval 9.5%-10.5%) of all respondents. Among those reporting pain, the prevalence of probable NeP among Blacks and Hispanics was consistently higher than Whites in each age- and sex group. The highest prevalence among those with pain was among male Hispanics 35-44 years (32.4%) and 45-54 years (24.2%) old. The most commonly used medications reported by those with probable NeP were nonsteroidal anti-inflammatory drugs (44.2%), followed by weak opioids (31.7%), antiepileptics (10.9%), and strong opioids (10.9%). This is the first study to provide an estimate of the prevalence of probable NeP in the US, showing significant variation by age and ethnicity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060375488

Download citation: RISBibTeXText

PMID: 29138590

DOI: 10.2147/JPR.S127014


Related references

Prevalence of chronic pain with neuropathic characteristics in the Moroccan general population: a national survey. Pain Medicine 14(2): 287-292, 2013

Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey. Pharmacoepidemiology and Drug Safety, 2018

The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. Journal of Pain 7(4): 281-289, 2006

The prevalence of pain in a general population. The results of a postal survey in a county of Sweden. Pain 37(2): 215-222, 1989

The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Medicine 10(5): 918-929, 2009

Prevalence of disabling abdominal pain and menstrual cramp. Results from a representative survey of the general German population. Schmerz 28(3): 259-264, 2015

Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136(3): 380-387, 2007

Estimates of the treated prevalence of bipolar disorders by mental health services in the general population: comparison of results from administrative and health survey data. Chronic Diseases and Injuries in Canada 31(3): 129-134, 2011

Modelling the prevalence and cost of back pain with neuropathic components in the general population. European Journal of Pain 13(10): 1030-1035, 2010

Stopnep: Study of prevalence of chronic and neuropathic pain in French general population. 2007

Do epidemiological results replicate? The prevalence and health-economic consequences of neck and back pain in the general population. European Journal of Pain 4(4): 347-354, 2000

Increased prevalence of psychotic disorders among third-generation migrants: results from the French Mental Health in General Population survey. Schizophrenia Research 147(1): 193-195, 2013

Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology 33(12): 587-595, 1998

Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine 34(4): 597-611, 2004

Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" survey (MHGP). European Psychiatry 26(6): 339-345, 2012